Skip redundant pieces
KU Center for Technology Commercialization
Inventors

    Innovation Sphere

Researchers

  • Steven Hoynowski
  • Kathy Mitchell

Communicate

Details

Project TitleDifferentiation of HUCM Cells into Hepatocyte Lineage Cells
Track Code06KU050L
Websitehttp://kuic.dept.ku.edu/sites/default/files/Differentiation_of_HUCM_Cells_into_Hepatocyte_Lineage_Cells_Technology_Profile.pdf
Short Description

This is a method for differentiating umbilical cord matrix stem cells into cells of the hepatocyte lineage that express albumin, alpha fetoprotein, cytochrome p450 isoforms and store glycogen.

AbstractNone
 
Tagsstem cells, HUCM Cells, Hepatocyte Lineage Cells
 
Posted DateSep 3, 2013 12:22 PM

Researcher

Name
Steven Hoynowski
Kathy Mitchell

Manager

Name
Matthew Koenig

Benefits

The differentiated human umbilical cord matrix (HUCM) cells have the ability to metabolize the drug indocyanine green, as liver cells do. The differentiated HUCM cells also resemble hepatocytes morphologically.

Applications

This source of cells provides the potential for genetic diversity by creating a bank of differentiated cells from diverse populations which would better represent the population at large. This is currently a weakness in drug screening studies early in the drug discovery process. Differentiated cells could also be applied to damaged liver tissue. Replacement of such tissue would provide an alternative to whole organ transplant by as a cell-based therapy or by growing the HUCM cells and differentiating them on a three dimensional scaffold to used as an artificial partial organ to restore loss of function in damaged liver.

Overview

The ability to direct HUCM stem cells to differentiate into hepatocytes extends the utility of this abundant source of stem cells for use in areas of drug research. For example, these cells could be used to test drug candidate molecules for their potential ability to produce hepatotoxicity, induction of cytochrome P450 gene expression, and inhibition of drug metabolic pathways. Realizing the goal of differentiating HUCM cells down the hepatocyte lineage would thereby provide a more readily available supply of human cells to be used in the assessment of possible drug-drug interactions.

Contact Information

Matt Koenig, J.D.

KU Center for Technology Commercialization (785) 864-1774 mekoenig@ku.edu

Intellectual Property

Patent Number Issue Date Type Country of Filing
US2008/0019949 None Utility United States


Page last modified: Thursday December 04, 2008  •  Valid XHTML  •  Copyright © 2008 by the University of Kansas